These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30981590)

  • 21. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
    Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
    Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
    Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Cipollari S; Carnicelli G; Bicchetti M; Campa R; Pecoraro M; Panebianco V
    Curr Opin Urol; 2020 May; 30(3):377-386. PubMed ID: 32168196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study.
    Daneshmand S; Ahmadi H; Huynh LN; Dobos N
    Urology; 2012 Dec; 80(6):1313-8. PubMed ID: 23040723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To determine correlation between VIRADS scoring and pathological staging in bladder cancer: A prospective study and review of literature.
    Gupta P; Sarangi SS; Singh M; Pandey H; Choudhary GR; Madduri VKS; Bhirud DP; Sandhu AS; Jena R
    Urologia; 2023 Aug; 90(3):476-481. PubMed ID: 36847430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
    Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
    Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
    Wang Y; Shen Y; Hu X; Li Z; Feng C; Hu D; Kamel IR
    AJR Am J Roentgenol; 2020 Feb; 214(2):383-389. PubMed ID: 31670586
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamic MRI of bladder cancer: evaluation of staging accuracy.
    Tekes A; Kamel I; Imam K; Szarf G; Schoenberg M; Nasir K; Thompson R; Bluemke D
    AJR Am J Roentgenol; 2005 Jan; 184(1):121-7. PubMed ID: 15615961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging muscle-invasive and metastatic urothelial carcinoma.
    Malayeri AA; Pattanayak P; Apolo AB
    Curr Opin Urol; 2015 Sep; 25(5):441-8. PubMed ID: 26222929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Salminen A; Jambor I; Merisaari H; Ettala O; Virtanen J; Koskinen I; Veskimae E; Sairanen J; Taimen P; Kemppainen J; Minn H; Boström PJ
    Cancer Imaging; 2018 Aug; 18(1):25. PubMed ID: 30068379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
    Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder cancer: evaluation of staging accuracy using dynamic MRI.
    Rajesh A; Sokhi HK; Fung R; Mulcahy KA; Bankart MJ
    Clin Radiol; 2011 Dec; 66(12):1140-5. PubMed ID: 21924408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.
    Metcalfe MJ; Ferguson JE; Li R; Xiao L; Guo CC; Czerniak BA; Siefker-Radtke A; Pretzsch SM; Navai N; McConkey DJ; Kamat AM; Campbell M; Dinney C
    Eur Urol Focus; 2017 Dec; 3(6):577-583. PubMed ID: 28753816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography.
    Tachibana M; Baba S; Deguchi N; Jitsukawa S; Hata M; Tazaki H; Tanimoto A; Yuasa Y; Hiramatsu K
    J Urol; 1991 Jun; 145(6):1169-73. PubMed ID: 2033686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinoma.
    Yaman O; Baltaci S; Arikan N; Yilmaz E; Gögüs O
    Br J Urol; 1996 Aug; 78(2):197-200. PubMed ID: 8813912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F; Chen HG; Zhang RY; Jin D; Xu SS; Wu GY; Xu JR
    Eur Radiol; 2019 Aug; 29(8):4447-4455. PubMed ID: 30666451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.